Attico, E.
Sceberras, V.
Pellegrini, G.
Article History
First Online: 2 August 2018
Compliance with Ethical Standards
:
: Prof. Pellegrini has a patent (EP Patent 1451302, May 28, 2008) licensed to Holostem Terapie Avanzate, and a patent (US Patent 6,610,538, Aug. 26, 2003) issued to Holostem Terapie Avanzate. Prof. Pellegrini is a member of the board of directors and R&D director of Holostem Terapie Avanzate.Dr. Attico E. declares no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.